9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer

NCT06079112 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Urothelial Carcinoma

Interventions

DRUG: 9MW2821
DRUG: Toripalimab

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.